Business

BACTIQ: Revenue up 16% to DKK 8.3m; Pharma and Aquaculture segments led growth; liquidity secured

BACTIQ: Revenue up 16% to DKK 8.3m; Pharma and Aquaculture segments led growth; liquidity secured

Bactiquant A/sMarch 18, 20264
BACTIQ: Revenue up 16% to DKK 8.3m; Pharma and Aquaculture segments led growth; liquidity secured

About this update from Bactiquant A/s

Revenue rose 16% to DKK 8.3 million, with Pharma and Aquaculture driving growth, while EBITDA loss was DKK 10.9 million. Two capital increases raised DKK 30 million, ensuring liquidity through 2027. 2026 guidance expects further revenue growth and reduced losses.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiquant A/s